22649-37-2

Basic information

• Product Name: 1-AMINO-CYCLOPENTANECARBOXYLIC ACID ETHYL ESTER HCL
• Synonyms: 1-AMINO-CYCLOPENTANECARBOXYLIC ACID ETHYL ESTER HCL;Ethyl 1-aminocyclopentanecarboxylate hydrochloride;Cyclopentanecarboxylic acid, 1-aMino-, ethyl ester, hydrochloride;1-Amino-cyclopentanecarboxylic acid ethyl ester hydrochloride;Ethyl 1-amino-cyclopentanecarboxylate HCl;ADFASIQRQWKXSJ-UHFFFAOYSA-N
• CAS NO: 22649-37-2
• Molecular Formula: C₈H₁₆NO₂*Cl
• Molecular Weight: 193.67
• Product Categories: pharmacetical
• Mol File: 22649-37-2.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 1-AMINO-CYCLOPENTANECARBOXYLIC ACID ETHYL ESTER HCL(CAS DataBase Reference)
• NIST Chemistry Reference: 1-AMINO-CYCLOPENTANECARBOXYLIC ACID ETHYL ESTER HCL(22649-37-2)
• EPA Substance Registry System: 1-AMINO-CYCLOPENTANECARBOXYLIC ACID ETHYL ESTER HCL(22649-37-2)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 22649-37-2(Hazardous Substances Data)

Usage

General Description

1-AMINO-CYCLOPENTANECARBOXYLIC ACID ETHYL ESTER HCL is a chemical compound that is a salt of the amino acid cyclopentanecarboxylic acid ethyl ester. It is commonly used in the synthesis of pharmaceuticals and as a building block for drug molecules. The HCL salt form of this compound is commonly used for ease of handling and storage, as well as for improved solubility in aqueous solutions. 1-AMINO-CYCLOPENTANECARBOXYLIC ACID ETHYL ESTER HCL is an important intermediate in organic synthesis and pharmaceutical research, and its properties make it a valuable tool for the development of new drugs and therapeutic agents.

Upstream product

• 110-52-1 1,4-dibromo-butane 
• 52-52-8 1-amino-1-cyclopentanecarboxylic acid 
• 64-17-5 ethanol 

Downstream Products

• 17193-28-1 1-aminocyclopentane-1-carboxamide 
• 90392-32-8 6,9-diaza-7,10-dioxospiro<4,5>decane 
• 145122-50-5 1-(2,4-difluorophenyl)-6-fluoro-7-(6,9-diazaspiro<4,5>decan-9-yl)-1,4-dihydro-4-oxo<1,8>naphthyridine-3-carboxylic acid trifluoroacetic acid salt 
• 145122-48-1 1-(2,4-difluorophenyl)-6-fluoro-7-(6,9-diazaspiro<4,5>decan-9-yl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid hydrochloride 
• 145122-71-0 ethyl 1-(2,4-difluorophenyl)-6-fluoro-7-(6,9-diazaspiro<4,5>decan-9-yl)-1,4-dihydro-4-oxo<1,8>naphthyridine-3-carboxylate 
• 145122-70-9 ethyl 1-(2,4-difluorophenyl)-6-fluoro-7-(6,9-diazaspiro<4,5>decan-9-yl)-1,4-dihydro-4-oxoquinoline-3-carboxylate 
• 145122-55-0 6,9-diazaspiro<4,5>decane dihydrochloride 
• 840506-50-5 phenyl (ethyloxy-L-cyclopentylglycinyl)phosphorochloridate 
• 93948-00-6 1-N-carbobenzyloxyglycylamino-1-ethoxycarbonylcyclopentane 

Relevant articles and documents

SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATIONS AND USES

The present invention relates to polysubstituted imidazolone derivatives, to the pharmaceutical compositions comprising them and to the therapeutic uses thereof in the human and animal health fields. The present invention also relates to a process for preparing these derivatives.

Wang-aldehyde resin as a recyclable support for the synthesis of α,α-disubstituted amino acid derivatives

Merrifield resin was functionalised with hydroxybenzaldehyde under microwave irradiation. The resultant resin was used as a means for immobilisation and activation of α-amino acid esters for alkylation reactions. α,α-Disubstituted and cyclic amino acid esters were prepared in good yields. The Royal Society of Chemistry 2005.

Composition for the treatment of damaged tissue

A pharmaceutical for use in damaged tissue, such as wound, treatment (e.g. healing) is described. The pharmaceutical comprising a composition which comprises: (a) a growth factor; and (b) an inhibitor agent; and optionally (c) a pharmaceutically acceptable carrier, diluent or excipient; wherein the inhibitor agent can inhibit the action of at least one specific adverse protein (e.g. a specific protease) that is upregulated in a damaged tissue, such as a wound, environment.